355 related articles for article (PubMed ID: 24889556)
1. Bronchoalveolar lavage fluid and blood natural killer and natural killer T-like cells in cryptogenic organizing pneumonia.
Papakosta D; Manika K; Gounari E; Kyriazis G; Kontakiotis T; Spyropoulos G; Kontakioti E; Zarogoulidis K
Respirology; 2014 Jul; 19(5):748-54. PubMed ID: 24889556
[TBL] [Abstract][Full Text] [Related]
2. Bronchoalveolar lavage fluid eosinophils are correlated to natural killer cells in eosinophilic pneumonias.
Papakosta D; Manika K; Kyriazis G; Kontakiotis T; Gioulekas D; Polyzoni T; Bouros D; Patakas D
Respiration; 2009; 78(2):177-84. PubMed ID: 19246876
[TBL] [Abstract][Full Text] [Related]
3. Innate immunity alterations in idiopathic interstitial pneumonias and rheumatoid arthritis-associated interstitial lung diseases.
Papanikolaou IC; Boki KA; Giamarellos-Bourboulis EJ; Kotsaki A; Kagouridis K; Karagiannidis N; Polychronopoulos VS
Immunol Lett; 2015 Feb; 163(2):179-86. PubMed ID: 25540922
[TBL] [Abstract][Full Text] [Related]
4. NK and NKT cells in the diagnosis of diffuse lung diseases presenting with a lymphocytic alveolitis.
Sokhatska O; Padrão E; Sousa-Pinto B; Beltrão M; Mota PC; Melo N; Delgado L; Morais A
BMC Pulm Med; 2019 Feb; 19(1):39. PubMed ID: 30760244
[TBL] [Abstract][Full Text] [Related]
5. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
6. Enhanced cytotoxic function of natural killer and natural killer T-like cells associated with decreased CD94 (Kp43) in the chronic obstructive pulmonary disease airway.
Hodge G; Mukaro V; Holmes M; Reynolds PN; Hodge S
Respirology; 2013 Feb; 18(2):369-76. PubMed ID: 23062183
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of NK cell percentages in bronchoalveolar lavage from patients with different fibrotic interstitial lung diseases.
Bergantini L; d'Alessandro M; Cameli P; Otranto A; Finco T; Curatola G; Sestini P; Bargagli E
Clin Immunol; 2021 Sep; 230():108827. PubMed ID: 34428741
[TBL] [Abstract][Full Text] [Related]
8. NK and NKT-like cells in granulomatous and fibrotic lung diseases.
Bergantini L; Cameli P; d'Alessandro M; Vagaggini C; Refini RM; Landi C; Pieroni MG; Spalletti M; Sestini P; Bargagli E
Clin Exp Med; 2019 Nov; 19(4):487-494. PubMed ID: 31485847
[TBL] [Abstract][Full Text] [Related]
9. Increased Galectin-9 Concentration and Number of CD4+Foxp3high+Cells in Bronchoalveolar Lavage Fluid of Patients with Cryptogenic Organizing Pneumonia.
Katoh S; Ikeda M; Shimizu H; Abe M; Ohue Y; Mouri K; Kobashi Y; Oka M
Lung; 2015 Oct; 193(5):683-9. PubMed ID: 26249221
[TBL] [Abstract][Full Text] [Related]
10. Expansion of pulmonary CD8+CD56+ natural killer T-cells in hypersensitivity pneumonitis.
Korosec P; Osolnik K; Kern I; Silar M; Mohorcic K; Kosnik M
Chest; 2007 Oct; 132(4):1291-7. PubMed ID: 17646229
[TBL] [Abstract][Full Text] [Related]
11. Bronchoalveolar lavage total cell count in interstitial lung diseases--does it matter?
Domagała-Kulawik J; Skirecki T; Maskey-Warzechowska M; Grubek-Jaworska H; Chazan R
Inflammation; 2012 Jun; 35(3):803-9. PubMed ID: 21882075
[TBL] [Abstract][Full Text] [Related]
12. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
Schildge J; Klar B; Hardung-Backes M
Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
[TBL] [Abstract][Full Text] [Related]
13. Activated CD8+ T cells and natural killer T cells in bronchoalveolar lavage fluid in hypersensitivity pneumonitis and sarcoidosis.
Tøndell A; Rø AD; Børset M; Moen T; Sue-Chu M
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):316-24. PubMed ID: 25591143
[TBL] [Abstract][Full Text] [Related]
14. NK cell populations in collagen vascular disease.
Papakosta D; Manika K; Kyriazis G; Kontakiotis T; Zarogoulidis K
Clin Exp Rheumatol; 2012; 30(5):693-9. PubMed ID: 22704071
[TBL] [Abstract][Full Text] [Related]
15. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.
Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S
Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187
[TBL] [Abstract][Full Text] [Related]
16. Can circulating interleukin-18 differentiate between sarcoidosis and idiopathic pulmonary fibrosis?
Liu DH; Cui W; Chen Q; Huang CM
Scand J Clin Lab Invest; 2011 Nov; 71(7):593-7. PubMed ID: 21834618
[TBL] [Abstract][Full Text] [Related]
17. [Subsets of lymphocytes in bronchoalveolar-lavage fluid from patients with idiopathic bronchiolitis obliterans organizing pneumonia].
Kusumoto H; Kunisawa A; Kuriyama Y; Yonemaru M; Nakano M; Ichinose Y; Ebihara Y; Toyama K
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 May; 34(5):529-35. PubMed ID: 8753110
[TBL] [Abstract][Full Text] [Related]
18. IL-9 and IL-9 receptor expression in lymphocytes from bronchoalveolar lavage fluid of patients with interstitial lung disease.
Jehn LB; Costabel U; Boerner E; Wessendorf TE; Theegarten D; Taube C; Bonella F
Immunobiology; 2022 Sep; 227(5):152258. PubMed ID: 35998415
[TBL] [Abstract][Full Text] [Related]
19. [Studies on the T-cell subset in lung tissue and BALF from patients with interstitial pneumonia].
Tada S; Namba J; Sugimoto K; Yokota S; Kitamura T; Irie S; Shiraishi T; Fujita T; Makimoto K; Kimura I
Arerugi; 1992 May; 41(5):577-83. PubMed ID: 1520067
[TBL] [Abstract][Full Text] [Related]
20. [The expression and clinical role of KL-6 in serum and BALF of patients with different diffuse interstitial lung diseases].
Zhu C; Zhao YB; Kong LF; Li ZH; Kang J
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):93-7. PubMed ID: 26879611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
